Goodwill And Intangible Assets

6 Months Ended

Aug. 02, 2014

Goodwill And Intangible Assets [Abstract]

Note 7

Goodwill and Intangible Assets

Goodwill and intangible assets were attributable to the Company's operating segments as follows:



	August 2,		August 3,		February 1,
($ thousands)		2014		2013		2014

Intangible Assets
Famous Footwear	$	2,800	$	2,800	$	2,800
Wholesale Operations		183,068		118,003		118,003
Specialty Retail		200		200		200
Total intangible assets		186,068		121,003		121,003
Accumulated amortization		(63,260)		(58,269)		(61,284)
Total intangible assets, net		122,808		62,734		59,719
Goodwill
Wholesale Operations		13,954		13,954		13,954
Total goodwill		13,954		13,954		13,954
Goodwill and intangible assets, net	$	136,762	$	76,688	$	73,673

Intangible assets consist primarily of owned and licensed trademarks, $21.0 million of which are not subject to amortization, with the remainder being amortized over useful lives ranging from four to 40 years as of August 2, 2014. Amortization expense related to intangible assets was $1.0 million and $1.5 million for the thirteen weeks and $2.0 million and $3.2 million for the twenty-six weeks ended August 2, 2014 and August 3, 2013, respectively.

On February 3, 2014, the Company entered into and simultaneously closed an Asset Purchase Agreement (the “Asset Purchase Agreement”), pursuant to which the Company acquired the Franco Sarto trademarks. As consideration, the Company paid a cash purchase price of $65.0 million at the time of closing. As a result of entering into and closing the Asset Purchase Agreement, the Company’s license agreement, granting the Company the right to sell footwear and other products using the Franco Sarto trademarks through 2019, was terminated. The purchase price of $65.0 million, as well as transaction costs of $0.1 million, will be amortized over its useful life of 40 years.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details